At present, a few factors correlated with BPH clinical progression have been identified, including age, serum prostate specific antigen (PSA), prostate volume, maximum flow rate, postvoid residual urine (PVRV) and international prostate symptom score (I-PSS) [6–7]. Here, KLK3 is linked to benign prostatic hyperplasia.